Why Is The Substance Opening in Nearly 2,000 Theaters?

Tom Brueggemann

    Tom Brueggemann has been Box Office Editor at IndieWire since 2016, a position he previously held at Gold Derby and Thompson on Hollywood. Unusual among entertainment journalists, he came to this after a more than three-decade career as an exhibitor, working as a film buyer in Chicago, New York, and Los Angeles for companies including M&R Theaters, Loews Theaters, and Sundance Cinemas. His film programming career began at Northwestern University, where he majored in political science before studying film in graduate school. He has also worked with multiple film festivals, including Sundance, as well as served as a juror. He also oversaw acquisition, marketing, and distribution for M&R Films which partnered with Cinecom Pictures. He has been a regular attendee at the Cannes, Toronto, and Sundance Film Festivals among others. As a writer, Tom brings to IndieWire what Gene Siskel earlier said about his earlier career: "His power as a most creative member of the Chicago film community derives from a variety of sources, first and foremost his film knowledge, and also his professional and personal friendships."

    He’s written about more than box office at IndieWire as well, including an acclaimed piece about how Fox News had the most important election desk leading into the 2020 election, and how the release of “The Fabelmans” may change distribution as much as “Jaws” did nearly 50 years earlier. Tom now lives in Palm Springs, CA.

    Latest by Tom Brueggemann
    The Substance
    GO BIG OR GO HOME
    These days, it makes sense to avoid limited runs for certain films. Here's why.
    Bill Skarsgård and FKA twigs in THE CROW. Photo Credit: Larry Horricks for Lionsgate
    VOD Report
    "Twisters," "Rebel Ridge," and "Inside Out 2" are all still strong.
    'Beetlejuice Beetlejuice,' Michael Keaton
    Weekend Box Office
    "Am I Racist?" is fourth, but not remotely at top Michael Moore agitprop doc level.
    David A.R. White in 'God's Not Dead: In God We Trust'
    GLORY BE
    This weekend, the "God's Not Dead" franchise entry and "Am I Racist?" should find the same box-office fate as other films for faith-based and far-right audiences.
    Aaron Pierre in Rebel Ridge
    VOD
    The production captured headlines three years ago when star John Boyega walked mid-production, but Aaron Pierre more than made up the difference.
    'BEETLEJUICE BEETLEJUICE,' Jenna Ortega
    Weekend Box Office
    "Reagan" drops 34 percent to finish third with "¡Casa Bonita Mi Amor!" the sole strong specialized opener (in Denver!)
    BEETLEJUICE BEETLEJUICE, (aka BEETLEJUICE 2), Michael Keaton, 2024. © Warner Bros. /Courtesy Everett Collection
    Box Office
    Films like "Transformers One" and "Speak No Evil" could continue the hot trends of summer 2024.
    'The Deliverance' (L to R) Caleb McGlaughlin as Nate and Andra Day as Ebony in The Deliverance. Cr. Aaron Ricketts/Netflix © 2024
    Four new releases make VOD top 10, while "Beetlejuice" is #6 at iTunes.
    'Reagan,' Dennis Quaid
    Weekend Box Office
    Box office takes a breather before "Beetlejuice, Beetlejuice" next Friday.
    LAS VEGAS, NEVADA - APRIL 09: Michael O’Leary, President & CEO, NATO, attends "The State of the Industry and a Special Presentation from Crunchyroll" during CinemaCon, the official convention of the National Association of Theatre Owners, at Caesars Palace on April 09, 2024 in Las Vegas, Nevada. (Photo by Jerod Harris/Getty Images for CinemaCon)
    The deeply discounted end-of-summer theatrical event was wildly popular in 2022 and 2023, but that's also part of the problem.
    INSIDE OUT 2
    Animation is everywhere: It's also six of the movies in the Netflix top 10.
    'BLINK TWICE,' Haley Joel Osment, 2024. © Amazon MGM Studios / courtesy Everett Collection
    Weekend Box Office
    With three weak theatrical debuts, we end the 11-week streak of $100 million+ box-office weekends.
    Top of The Line Weekly
    A weekly digest that captures the best of our Top of the Line coverage.

    By providing your information, you agree to our Terms of Use and our Privacy Policy. We use vendors that may also process your information to help provide our services. This site is protected by reCAPTCHA Enterprise and the Google Privacy Policy and Terms of Service apply.